EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor‐Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P‐Selectin/PSGL1 N‐Glycosylation Blockage

Xiaojing Du iD, Zhuoran Qi, Sinuo Chen, Jinlan Wu, Ye Xu, Sunkuan Hu, Zhijie Yu, Jiayun Hou, Yuan Fang, Jinglin Xia iD, Xin Cao iD

Advanced Science · 2025

DOI: 10.1002/advs.202407519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaojing Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, P-Selectin, Membrane Glycoproteins, Cytoskeleton. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Extraordinary 2025 Elite Project of Fudan University, Key Laboratory of diagnosis and treatment of severe hepato-pancreatic diseases of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (ICC) is a highly lethal malignancy that currently lacks effective clinical treatments. Eliminating stem cell‐like cancer cells is an extremely promising but challenging strategy for treating ICC. A recently developed synthetic retinoid, sulfarotene, abrogates proliferation, and induces apoptosis of tumor‐repopulating cells (TRCs) that exhibit stem cell‐like properties, yet its effect and underlying mechanisms remain elusive in ICC. It is found that although 5‐fluorouracil, cisplatin, pemigatinib, and gemcitabine all inhibit ICC‐TRCs, sulfarotene demonstrates superior efficacy. Sulfarotene induces retinoic acid receptor alpha (RARɑ) translocation from the cytoplasm to the nucleus, suppressing P‐selectin expression at the transcriptional level. Moreover, it directly interacts with fucosyltransferase 8 (FUT8), inhibiting the core fucosylation of P‐selectin glycoprotein ligand 1 (PSGL1). These actions collectively inhibit ICC‐TRCs via destroying PSGL1‐regulated cytoskeleton. The findings provide a strategy of inhibiting P‐selectin/PSGL1 interaction and altering PSGL1 glycosylation pattern to compromise the cytoskeletal integrity and eliminate ICC‐TRCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaP-SelectinMembrane GlycoproteinsCytoskeletonBile Duct NeoplasmsRetinoidsHumansGlycosylationAnimalsMiceCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

P‐selectin/PSGL1core fucosylationcytoskeletonintrahepatic cholangiocarcinomasynthetic retinoidtumor‐repopulating cells

Substanzen

P-selectin ligand proteinP-SelectinMembrane GlycoproteinsRetinoids

Autor:innen und Institutionen

  • Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
  • Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Department of Pediatrics, Jiading District Central Hospital, Shanghai, 201800, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.

ORCID-Profile: Xiaojing Du, Jinglin Xia, Xin Cao

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Extraordinary 2025 Elite Project of Fudan University, Key Laboratory of diagnosis and treatment of severe hepato-pancreatic diseases of Zhejiang Province
  • Pudong New District Health Commission Science and Technology Projects
  • National Key Research and Development Program of China

Zitieren

APA

Du, X., Qi, Z., Chen, S., Wu, J., Xu, Y., Hu, S., Yu, Z., Hou, J., Fang, Y., Xia, J., & Cao, X. (2025). Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor‐Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P‐Selectin/PSGL1 N‐Glycosylation Blockage. Advanced Science. https://doi.org/10.1002/advs.202407519

Vancouver

Du X, Qi Z, Chen S, Wu J, Xu Y, Hu S, et al. Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor‐Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P‐Selectin/PSGL1 N‐Glycosylation Blockage. Advanced Science. 2025. doi:10.1002/advs.202407519

BibTeX
@article{Du2025,
  author = {Du, Xiaojing and Qi, Zhuoran and Chen, Sinuo and Wu, Jinlan and Xu, Ye and Hu, Sunkuan and Yu, Zhijie and Hou, Jiayun and Fang, Yuan and Xia, Jinglin and Cao, Xin},
  title = {Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor‐Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P‐Selectin/PSGL1 N‐Glycosylation Blockage},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202407519}
}
Kostenlos starten →